These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32212000)

  • 41. Redox proteomics gives insights into the role of oxidative stress in alkaptonuria.
    Braconi D; Millucci L; Ghezzi L; Santucci A
    Expert Rev Proteomics; 2013 Dec; 10(6):521-35. PubMed ID: 24206226
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transient pockets as mediators of gas molecules routes inside proteins: The case study of dioxygen pathway in homogentisate 1,2-dioxygenase and its implication in Alkaptonuria development.
    Bernini A; Galderisi S; Spiga O; Amarabom CO; Santucci A
    Comput Biol Chem; 2020 Oct; 88():107356. PubMed ID: 32823072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. aku, a mutation of the mouse homologous to human alkaptonuria, maps to chromosome 16.
    Montagutelli X; Lalouette A; Coudé M; Kamoun P; Forest M; Guénet JL
    Genomics; 1994 Jan; 19(1):9-11. PubMed ID: 8188247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toward a generalized computational workflow for exploiting transient pockets as new targets for small molecule stabilizers: Application to the homogentisate 1,2-dioxygenase mutants at the base of rare disease Alkaptonuria.
    Bernini A; Galderisi S; Spiga O; Bernardini G; Niccolai N; Manetti F; Santucci A
    Comput Biol Chem; 2017 Oct; 70():133-141. PubMed ID: 28869836
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel mutations in the homogentisate 1,2 dioxygenase gene identified in Jordanian patients with alkaptonuria.
    Al-sbou M
    Rheumatol Int; 2012 Jun; 32(6):1741-6. PubMed ID: 21437689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel mutations in the homogentisate-1,2-dioxygenase gene identified in Slovak patients with alkaptonuria.
    Zatková A; Polaková H; Micutková L; Zvarík M; Bosák V; Feráková E; Matusek J; Ferák V; Kádasi L
    J Med Genet; 2000 Jul; 37(7):539-42. PubMed ID: 10970188
    [No Abstract]   [Full Text] [Related]  

  • 47. Alkaptonuria in Russia: mutational spectrum and novel variants.
    Bychkov I; Kamenets E; Kurkina M; Rychkov G; Ilyushkina A; Filatova A; Guseva D; Baydakova G; Nekrasov A; Cheblokov A; Skoblov M; Zakharova E
    Eur J Med Genet; 2021 Apr; 64(4):104165. PubMed ID: 33621656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alkaptonuria: a very rare metabolic disorder.
    Aquaron R
    Indian J Biochem Biophys; 2013 Oct; 50(5):339-44. PubMed ID: 24772955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of Potential Inhibitors for the Treatment of Alkaptonuria Using an Integrated In Silico Computational Strategy.
    Zaib S; Rana N; Hussain N; Ogaly HA; Dera AA; Khan I
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural and functional analysis of mutations in alkaptonuria.
    Rodríguez JM; Timm DE; Titus GP; Beltrán-Valero De Bernabé D; Criado O; Mueller HA; Rodríguez De Córdoba S; Peñalva MA
    Hum Mol Genet; 2000 Sep; 9(15):2341-50. PubMed ID: 11001939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A molecular spectroscopy approach for the investigation of early phase ochronotic pigment development in Alkaptonuria.
    Bernini A; Petricci E; Atrei A; Baratto MC; Manetti F; Santucci A
    Sci Rep; 2021 Nov; 11(1):22562. PubMed ID: 34799606
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Presentation of 14 alkaptonuria patients from Turkey.
    Akbaba AI; Ozgül RK; Dursun A
    J Pediatr Endocrinol Metab; 2020 Feb; 33(2):289-294. PubMed ID: 31927521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Machine learning application for patient stratification and phenotype/genotype investigation in a rare disease.
    Spiga O; Cicaloni V; Dimitri GM; Pettini F; Braconi D; Bernini A; Santucci A
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33538294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. R58fs mutation in the HGD gene in a family with alkaptonuria in the UAE.
    Abdulrazzaq YM; Ibrahim A; Al-Khayat AI; Nagelkerke N; Ali BR
    Ann Hum Genet; 2009 Jan; 73(1):125-30. PubMed ID: 18945288
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ochronotic rheumatism in Algeria: clinical, radiological, biological and molecular studies--a case study of 14 patients in 11 families.
    Ladjouze-Rezig A; Rodriguez de Cordoba S; Aquaron R
    Joint Bone Spine; 2006 May; 73(3):284-92. PubMed ID: 16085442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of the Phenotype Differences in Siblings with Alkaptonuria.
    Zatkova A; Olsson B; Ranganath LR; Imrich R
    Metabolites; 2022 Oct; 12(10):. PubMed ID: 36295892
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone.
    Preston AJ; Keenan CM; Sutherland H; Wilson PJ; Wlodarski B; Taylor AM; Williams DP; Ranganath LR; Gallagher JA; Jarvis JC
    Ann Rheum Dis; 2014 Jan; 73(1):284-9. PubMed ID: 23511227
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alkaptonuria in France: past experience and lessons for the future.
    Aquaron RR
    J Inherit Metab Dis; 2011 Dec; 34(6):1115-26. PubMed ID: 21927854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The genetic defect of the alkaptonuric mouse (aku).
    Kress W; Schmidt SR; Halliger-Keller B; Montagutelli X; Müller CR
    Mamm Genome; 1999 Jan; 10(1):68-70. PubMed ID: 9892737
    [No Abstract]   [Full Text] [Related]  

  • 60. Molecular defects in alkaptonuria.
    Gehrig A; Schmidt SR; Müller CR; Srsen S; Srsnova K; Kress W
    Cytogenet Cell Genet; 1997; 76(1-2):14-6. PubMed ID: 9154114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.